How many stocks are there of Amedisys?
The current number of stocks of Amedisys is 32.6 M undefined.
Amedisys Stocks 2024
Amedisys Stocks
32.6 M
Ticker
AMED
ISIN
US0234361089
WKN
915582
In 2024, Amedisys had 32.6 M outstanding stocks, a 0% change from the 32.6 M stocks in the previous year.
The Amedisys Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2026e | 32.6 |
| 2025e | 32.6 |
| 2024e | 32.6 |
| 2023 | 32.6 |
| 2022 | 32.7 |
| 2021 | 33 |
| 2020 | 33.3 |
| 2019 | 33 |
| 2018 | 33.6 |
| 2017 | 34.3 |
| 2016 | 33.7 |
| 2015 | 33 |
| 2014 | 32.8 |
| 2013 | 31.2 |
| 2012 | 29.9 |
| 2011 | 28.7 |
| 2010 | 28.5 |
| 2009 | 27.8 |
| 2008 | 26.9 |
| 2007 | 26.3 |
| 2006 | 22.3 |
| 2005 | 21.3 |
| 2004 | 18.1 |
Amedisys shares outstanding US0234361089 · 915582
The number of shares was Amedisys in 2023 — This indicates how many shares 32.599 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Amedisys earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Amedisys's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Amedisys’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Amedisys's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 18.1 M Aktien |
| 2005 | 21.3 M Aktien |
| 2006 | 22.3 M Aktien |
| 2007 | 26.3 M Aktien |
| 2008 | 26.9 M Aktien |
| 2009 | 27.8 M Aktien |
| 2010 | 28.5 M Aktien |
| 2011 | 28.7 M Aktien |
| 2012 | 29.9 M Aktien |
| 2013 | 31.2 M Aktien |
| 2014 | 32.8 M Aktien |
| 2015 | 33 M Aktien |
| 2016 | 33.7 M Aktien |
| 2017 | 34.3 M Aktien |
| 2018 | 33.6 M Aktien |
| 2019 | 33 M Aktien |
| 2020 | 33.3 M Aktien |
| 2021 | 33 M Aktien |
| 2022 | 32.7 M Aktien |
| 2023 | 32.6 M Aktien |
| 2024e | 32.6 M Aktien |
| 2025e | 32.6 M Aktien |
| 2026e | 32.6 M Aktien |
Amedisys Aktienanalyse
What does Amedisys do?
Amedisys Inc is a US home healthcare provider that offers a variety of healthcare services in the private home, including home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. The company was founded in 1982 by William F. Borne and Michael J. Borne and is headquartered in Baton Rouge, Louisiana. History In the 1980s, while William and Michael Borne were running a nursing home together, they recognized a demand for home healthcare and founded Amedisys in 1982. The company started with a small group of nurses making house calls and was based on the belief that people would prefer to be cared for at home rather than being placed in a facility. In 1999, Amedisys was acquired by the American Stock Exchange and was able to steadily improve its performance and expand its business model to multiple states. In 2007, the company went public and has been listed on NASDAQ since. Business Model Amedisys offers a wide range of healthcare services that are typically received by patients at home. The services include home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. Amedisys collaborates with over 360 medical faculties and over 7,500 medical professionals who provide healthcare to over 385,000 patients per year. Amedisys also offers training programs for nurses and other employees to discover the business and potential growth opportunities. The company relies on teamwork to motivate staff and keep their knowledge and skills up-to-date. Segments Amedisys operates in two main business segments: home healthcare and hospice care. Both segments offer specialized services and are provided by professionals such as registered nurses, therapists, medical assistants, and social workers. The company has more than 435 hospice facilities in 34 US states and over 197 home healthcare branches in 38 US states. Products Amedisys offers a variety of products, including infusion therapy, professional wound management, clinical respiratory therapy, polypharmacy management, specialized care services, and palliative care. The company also provides telemedicine options for patients to receive care from home. Summary Amedisys is a leading provider of home healthcare and hospice care in the US. The company offers a wide range of services and is able to serve both the inpatient and outpatient settings. The company relies on teamwork to provide comprehensive and high-quality care to patients. Amedisys is a successful and expanding company that is also exploring new market potentials through the use of technology. Amedisys ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Amedisys's Shares Outstanding
Amedisys's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Amedisys’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Amedisys’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Amedisys’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Amedisys Stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Amedisys are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Amedisys evolved in recent years?
The number of shares of Amedisys has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Amedisys as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Amedisys?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Amedisys pay?
Over the past 12 months, Amedisys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amedisys is expected to pay a dividend of 0 USD.
What is the dividend yield of Amedisys?
The current dividend yield of Amedisys is .
When does Amedisys pay dividends?
Amedisys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Amedisys?
Amedisys paid dividends every year for the past 0 years.
What is the dividend of Amedisys?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Amedisys located?
Amedisys is assigned to the 'Health' sector.
Wann musste ich die Aktien von Amedisys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Amedisys from 6/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/28/2024.
When did Amedisys pay the last dividend?
The last dividend was paid out on 6/28/2024.
What was the dividend of Amedisys in the year 2023?
In the year 2023, Amedisys distributed 0 USD as dividends.
In which currency does Amedisys pay out the dividend?
The dividends of Amedisys are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Amedisys stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Amedisys
Our stock analysis for Amedisys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amedisys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
